Inovio Pharmaceuticals, Inc.

INONASDAQHealthcare● Active

$1.13

+$0.04(+3.21%)

Market Cap$60288597

P/E Ratio—

52W High$2.98

52W Low$1.03

Avg Volume2.6M

Open$1.09

Beta1.49

Employees Ownership Insider Trades

Inovio Pharmaceuticals, Inc. (INO) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · INO · as of Mar 12, 2026

Latest filing snapshot

112

-22-16.42%vs prior year

Inovio Pharmaceuticals, Inc. (INO) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

112

Change (1Y)

-22

Growth % (1Y)

-16.42%

Revenue / Employee

$583

Net Income / Employee

$-758.4K

Market Cap

$58M

INO Employee Count

1999 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-03-12	2025-12-31	112	-22	-16.42%
2025-03-18	2024-12-31	134	+12	+9.84%
2024-03-06	2023-12-31	122	-62	-33.70%
2023-03-01	2022-12-31	184	-133	-41.96%
2022-03-01	2021-12-31	317	+55	+20.99%
2021-03-01	2020-12-31	262	+72	+37.89%
2020-03-12	2019-12-31	190	-91	-32.38%
2019-03-12	2018-12-31	281	+3	+1.08%
2018-03-14	2017-12-31	278	+39	+16.32%
2017-03-15	2016-12-31	239	+82	+52.23%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

Fate Therapeutics, Inc.

Inovio Pharmaceuticals, Inc.YOU

112$58M #5

ABOS

Acumen Pharmaceuticals, Inc.

Actuate Therapeutics Inc

10$44M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · INO peer comparison

About INO employees

INO Employees · Headcount

Inovio Pharmaceuticals, Inc. (INO) employee data is sourced from the annual SEC 10-K filing. As of 2025, Inovio Pharmaceuticals, Inc. had 112 full-time employees globally. Full-time employees only. Global consolidated headcount.

Inovio Pharmaceuticals, Inc. employs 112 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $583, reflecting the company's operational efficiency.

Inovio Pharmaceuticals, Inc.'s workforce decreased by 22 (16.42%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Inovio Pharmaceuticals, Inc.'s revenue per employee of $583 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

INO Employees · 5 questions

As of the latest SEC 10-K filing (2025), Inovio Pharmaceuticals, Inc. had 112 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Inovio Pharmaceuticals, Inc. employee counthow many employees does Inovio Pharmaceuticals, Inc. haveINO total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-12